Impairment of optokinetic nystagmus in patients with tardive dyskinesia.
D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects; D001288:Attention; D005133:Eye Movements; D005260:Female; D005403:Fixation, Ocular; D006801:Humans; D006816:Huntington Disease / Q000503:physiopathology; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy; D008875:Middle Aged; D009039:Motion Perception; D009069:Movement Disorders / Q000139:chemically induced / Q000503:physiopathology*; D009801:Oculomotor Muscles / Q000503:physiopathology; D010300:Parkinson Disease / Q000503:physiopathology; D010640:Phenothiazines; D012399:Rotation
D014150:Antipsychotic Agents; D010640:Phenothiazines